OVERVIEW

Rapid developments in methods for cardiovascular (CV) disease risk evaluation and recent advances in pharmacological and procedural strategies for management of cardiometabolic risk factors have significantly improved our ability to identify and treat at-risk patients. Join our internationally renowned faculty for updates on contemporary understanding of cardiovascular disease risk algorithms, polygenic risk scores, biomarkers and CV risk, preventive imaging, and female specific risk factors and learn how to incorporate strategies for personalization of risk assessment for each of your unique patients. Develop skills in recognizing the early, multi-system signs of cardiometabolic disease beyond the heart, including metabolic liver and renal diseases and consider newer pharmacological strategies for organ protection. Targeting obesity is now imperative, particularly in at-risk patients early in the cardiometabolic continuum. Advance your skills in designing a comprehensive management strategy that includes lifestyle, as well as groundbreaking anti-obesity medications and surgical approaches to weight management. The landscape of lipid pharmacotherapy has never been more expansive and the most recent expert guidance on incorporation of these agents into clinical practice will be considered. Presentations of complex patient cases from the real-world will stimulate challenging discussions among participants and expert panelists. And just to keep you at the absolute peak of your scientific evidence game, join us for a session on the Top Trials of 2026-27 in preventive cardiology and cardiometabolic health that will impact your patient care! | Objectives: Incorporate the new PREVENT CV Risk equations, risk enhancers, and imaging into routine clinical practice to personalize evaluation of the individual patient; Formulate management strategies to target obesity as a key driver of the cardiovascular kidney metabolic disease risk continuum; Select pharmacotherapy for management of dyslipidemia and hypertension based on current scientific evidence and expert guidance.

KEY DATES

Event Start Date
05 Mar, 2027
Event Start Date
Event End Date
06 Mar, 2027
Event End Date
Credits

The Medical University of South Carolina is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

AMA PRA Category 1: AMA PRA Category 1 Credits™ (9.75 hours), Non-Physician Attendance (9.75 hours)

MOC: Successful completion of this CME activity enables the participant to earn MOC points.

  • 9.75 AMA PRA Category 1
  • 9.75 MOC
  • TARGET AUDIENCE

    PhysicianNurse PractitionerHealthcare ProvidersAllied Health ProfessionalsAdvanced Practice ProvidersPhysician AssistantResearch scientistsPrimary Clinicians

    SPECIALITIES

    CardiologyPrimary CareInternal Medicine

    SUGGESTED HOTELS

    CONFERENCE VENUE

    LocationHyatt Hotel
    560 King Street

    RELATED CONFERENCES & LIVE WEBINARS